Covilife 12 mg

When used for a confirmed susceptible parasitic infection, Covilife 12 mg can:

• Reduce the number of susceptible parasites

• Help clear strongyloidiasis

• Control microfilariae in onchocerciasis

• Reduce scabies mite activity

• Improve parasite-related itching and skin symptoms

• Support recovery from diagnosed parasitic infections

The benefits depend on correct diagnosis and weight-based dosing. Covilife does not provide these benefits for infections or skin conditions that do not respond to ivermectin.

Cancer and COVID-19 research provides reasons for further scientific investigation but does not establish treatment benefits for either condition.

Ivermectin attaches to chloride channels found in the nerve and muscle cells of susceptible parasites. This increases the movement of chloride ions into the cells and disrupts normal nerve signals.

The affected parasites become paralysed and die or lose their ability to remain inside the body. The body then removes them naturally. The medicine only works against parasites that are sensitive to ivermectin.

In cancer research, scientists are studying whether ivermectin affects cancer-cell signalling and the immune response around tumours. These mechanisms remain under investigation and are separate from its established antiparasitic action.

Ivermectin dosage is calculated using body weight and the diagnosed infection. A 12 mg tablet does not represent the correct dose for every person or condition.

For strongyloidiasis, oral ivermectin is commonly prescribed at approximately 200 micrograms per kilogram of body weight as a single dose. For onchocerciasis, the usual calculated dose is approximately 150 micrograms per kilogram. Scabies treatment follows a different schedule and often requires a repeat dose after a defined interval.

These are general ivermectin dosing references and should not be used to select a personal dose. The number of Covilife 12 mg tablets and the need for repeat treatment must be determined from the diagnosis, body weight and treatment guidance.

Swallow the prescribed dose with water. Many oral ivermectin labels direct patients to take it on an empty stomach, but the instructions supplied with Covilife and the healthcare professional’s directions should be followed.

There is no established Covilife 12 mg dosage for COVID-19 or cancer yet, as the clinical trials are still ongoing. Do not copy doses used in clinical trials or online treatment schedules without consultation.

Common Side Effects: Covilife 12 mg can cause nausea, diarrhoea, abdominal discomfort, dizziness, headache, tiredness, itching or a skin rash. Some symptoms occur as the body reacts to dying parasites. Contact a healthcare professional if these effects continue or become difficult to manage.

Serious Side Effects: Seek urgent medical attention for facial or throat swelling, breathing difficulty, fainting, severe skin reactions, confusion, seizures, difficulty walking, unusual sleepiness, vision changes or yellowing of the skin or eyes. People with a heavy Loa loa infection can develop a serious neurological reaction after ivermectin treatment.

Covilife 12 mg should be avoided or used only after professional assessment by:

• People allergic to ivermectin

• Children weighing under 15 kg

• Pregnant or breastfeeding women

• People with severe liver disease

• People with suspected Loa loa infection

• People taking warfarin

• People using strong CYP3A4 medicines

• People seeking COVID-19 self-treatment

• People seeking cancer self-treatment

Tell the healthcare professional about all medicines, supplements and herbal products being used.

Important interactions include:

• Warfarin and other anticoagulants

• Strong CYP3A4 inhibitors

• Strong CYP3A4 inducers

• Other antiparasitic medicines

• Sedating medicines

• Chemotherapy medicines

• Immunotherapy medicines

Do not combine Covilife with another ivermectin product or an experimental cancer or COVID-19 treatment without professional review.

• Store Covilife 12 mg below 25°C.

• Keep the tablets in their original packaging.

• Protect them from heat and moisture.

• Keep the pack away from direct sunlight.

• Store it out of reach of children and pets.

• Do not use tablets from damaged packaging.

• Check the expiry date before use.

• Dispose of expired tablets according to local requirements.